Hypokalemia in Patients with COVID-19
Tóm tắt
Patients with COVID-19 experience multiple clinical conditions that may cause electrolyte imbalances. Hypokalemia is a concerning electrolyte disorder closely associated with severe complications. This study aimed to estimate prevalence, risk factors and outcome of hypokalemia in a cohort of patients with confirmed COVID-19. A retrospective analysis was conducted on 290 non-ICU admitted patients with COVID-19 at the tertiary teaching hospital of Modena, Italy, from February 16 to April 14, 2020. Hypokalemia was detected in 119 out of 290 patients (41%) during hospitalization. Mean serum potassium was 3.1 ± 0.1 meq/L. The majority of patients (90.7%) patients experienced only a mild decrease in serum potassium level (3–3.4 mEq/L). Hypokalemia was associated with hypocalcemia, which was detected in 50% of subjects. Urine potassium-to-creatinine ratio, measured in a small number of patients (n = 45; 36.1%), revealed an increase of urinary potassium excretion in most cases (95.5%). Risk factors for hypokalemia were female sex (odds ratio (OR) 2.44; 95% CI 1.36–4.37; P 0.003) and diuretic therapy (OR 1.94, 95% CI 1.08–3.48; P 0.027). Hypokalemia, adjusted for sex, age and SOFA score, was not associated with ICU transfer (OR 0.52; 95% CI 0.228–1.212; P = 0.131), in-hospital mortality (OR, 0.47; 95% CI 0.170–1.324; P = 0.154) and composite outcome of ICU transfer or in-hospital mortality (OR 0.48; 95% CI 0.222–1.047; P = 0.065) in our cohort of patients. Hypokalemia was a frequent disorder in subjects with COVID-19. Female sex and diuretic therapy were identified as risk factors for low serum potassium levels. Hypokalemia was unrelated to ICU transfer and death in this cohort of patients.
Tài liệu tham khảo
COVID-19 Map;Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Internet]. Johns Hopkins Coronavirus Resour Cent. [cited 2020 May 15]. https://coronavirus.jhu.edu/map.html
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323(13):1239–42.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Feb;0(0):null.
Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. The Lancet. 2020;395(10228):e52.
Moore BJB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020. https://doi.org/10.1126/science.abb8925.
Garg S. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019—COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69. DOI: https://doi.org/10.15585/mmwr.mm6915e3
Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(3):247–50.
Basu-Ray I, Soos MP. Cardiac Manifestations Of Coronavirus (COVID-19). StatPearls. Treasure Island (FL): StatPearls Publishing; 2020; [cited 2020 May 30]. http://www.ncbi.nlm.nih.gov/books/NBK556152/
Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801–9.
Li N, Wang G, Wu Y, Xie G, Xiao F, Chen B, et al. Side effects of glucocorticosteroids in the management of 1291 patients of SARS. Beijing Da Xue Xue Bao. 2004;36(5):519–24.
Su H, Yang M, Wan C, Yi L-X, Tang F, Zhu H-Y, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020 Apr;0(0). DOI: https://doi.org/10.1016/j.kint.2020.04.003
WHO/COVID-19/laboratory/2020.5. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases [Internet]. [cited 2020 Apr 12]. https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117
Kidney Disease: Improving Global Outcomes (KDIGO) Acute kidney injury work group. KDIGO Clinical practice guideline for acute kidney injury. Kidney inter., Suppl. 2012; 2: 1–138. 2012;141.
Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: a clinical update. Endocr Connect. 2018;7(4):R135–46.
Yalamanchili HB, Calp-Inal S, Zhou XJ, Choudhury D. Hypokalemic nephropathy. Kidney Int Rep. 2018;3(6):1482–8.
Jędrusik P, Symonides B, Wojciechowska E, Gryglas A, Gaciong Z. Diagnostic value of potassium level in a spot urine sample as an index of 24-h urinary potassium excretion in unselected patients hospitalized in a hypertension unit. PLoS ONE. 2017;12(6):e0180117.
Alfano G, Guaraldi G, Fontana F, Ferrari A, Magistroni R, Mussini C, et al. The role of the renin-angiotensin system in severe acute respiratory syndrome-CoV-2 infection. Blood Purif. 2020 1–5.
Arampatzis S, Funk G-C, Leichtle AB, Fiedler G-M, Schwarz C, Zimmermann H, et al. Impact of diuretic therapy-associated electrolyte disorders present on admission to the emergency department: a cross-sectional analysis. BMC Med. 2013;11:83.
Sagild U. Total exchangeable potassium in normal subjects with special reference to changes with age. Scand J Clin Lab Invest. 1956;8(1):44–50.
Bowling CB, Pitt B, Ahmed MI, Aban IB, Sanders PW, Mujib M, et al. Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ Heart Fail. 2010;3(2):253–60.
Goyal A, Spertus JA, Gosch K, Venkitachalam L, Jones PG, den Berghe GV, et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA. 2012;307(2):157–64.
Gennari FJ. Disorders of potassium homeostasis. Hypokalemia and hyperkalemia. Crit Care Clin. 2002 18(2):273–88, vi.
Paice BJ, Paterson KR, Onyanga-Omara F, Donnelly T, Gray JM, Lawson DH. Record linkage study of hypokalaemia in hospitalized patients. Postgrad Med J. 1986;62(725):187–91.
Asmar A, Mohandas R, Wingo CS. A physiologic-based approach to the treatment of a patient with hypokalemia. Am J Kidney Dis Off J Natl Kidney Found. 2012;60(3):492–7.
Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011;7(2):75–84.
Palmer BF. Regulation of potassium homeostasis. Clin J Am Soc Nephrol CJASN. 2015;10(6):1050–60.
Chen D, Li X, Song Q, Hu C, Su F, Dai J, et al. Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China. JAMA Netw Open. 2020;3(6). DOI: https://doi.org/10.1001/jamanetworkopen.2020.11122
Holdsworth SR, Gan P-Y. Cytokines: names and numbers you should care about. Clin J Am Soc Nephrol CJASN. 2015;10(12):2243–54.
Alfano G, Ferrari A, Fontana F, Perrone R, Mori G, Ascione E, et al. Hypokalemia in Patients with COVID-19. medRxiv. 2020;2020.06.14.20131169.